In Depth 11 Dec 2024 Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy? Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy. December 11, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 11 Dec 2024Antibody Therapy R&D trends and breakthrough innovations Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart. December 11, 2024 Share WhatsApp Twitter Linkedin Email Produced by Inpart
More News! 10 Dec 2024 Biotech in 2024: A retrospective 2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism? December 10, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2024 CAR-T cell therapy for lupus: An emerging field with great potential Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder. December 9, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 6 Dec 2024Cracking the code of biotech valuations Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom. December 6, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 5 Dec 2024 The biggest private biotech investments in November 2024 The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024. December 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Dec 2024 Five biosimilar companies you should know about Discover five biosimilar companies creating affordable versions of blockbuster drugs and hoping to capitalize on the upcoming patent cliff. December 5, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Dec 2024 Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments There is a lot of research going on in the therapeutic field of idiopathic pulmonary fibrosis, in the hope that more treatments reach patients sooner. December 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Dec 2024 Twelve gift ideas for a biotech enthusiast this holiday season Explore our curated list of biotechnology-themed gifts, ranging from captivating board games to engaging DIY biology kits. December 3, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by KBI Biopharma 3 Dec 2024 Process intensification: Fueling biopharma success at warp speed Learn about process intensification in biopharma, key strategies for success, and solutions to overcome manufacturing challenges. December 3, 2024 - 5 minutesmins - By Will Chu Share WhatsApp Twitter Linkedin Email
In Depth 2 Dec 2024 The rise of cancer vaccines: A new era in immunotherapy Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors. December 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2024 Trump’s healthcare picks: Who they are and what they mean for the biopharma industry Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.? November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email